Abstract: The present disclosure provides a manufacturing method of a semiconductor structure and a semiconductor structure and relates to the technical field of semiconductors. The manufacturing method of a semiconductor structure includes: providing a substrate, where the substrate includes a first region and a second region, the first region includes a plurality of independent first active regions, adjacent two of the first active regions are isolated by a first trench, and an isolating lamination layer is formed in the first trench; forming a barrier layer covering a top surface of the second region; forming an epitaxial layer covering a top surface of the first active region; and etching off the barrier layer and part of the isolating lamination layer in the first region, where joints of top surfaces of layers in the isolating lamination layer retained in the first region are basically consistent in height.

Abstract: The present subject matter relates to systems and methods for the formulation of inks from stock solutions in which a liquid handler is configured to draw samples from a plurality of solution components and mix the components together to create one or more ink formulations, and a dispensing robot is configured to transfer the one or more ink formulations to a common substrate to form one or more material samples or a coating element in communication with the liquid handler is configured to transfer the one or more ink formulations to a common substrate to form one or more material samples. A controller in communication with each of the liquid handler and the dispensing robot can be configured to coordinate the creation and transfer of the one or more ink formulations. In addition, the one or more material samples can be analyzed using one or more characterization instrument configured to characterize the material samples on the common substrate.

Abstract: A cholinesterase inhibitor polymorph, wherein specifically disclosed are a octahydroaminoacridine succinate polymorph, a corresponding crystal composition and pharmaceutical composition, and applications thereof. The compound octahydroaminoacridine succinate is used for screening and studying polymorphs, and the discovered polymorphs are appraised and evaluated; crystal forms having better physical and chemical properties are determined for subsequent development and study, and crystal forms having good stability and an excellent therapeutic effect are obtained.

Abstract: The disclosure provides a FDSOI semiconductor structure and methods to fabricate it. The structure includes source and drain regions and gates respectively in an NMOS area and a PMOS area, a first oxide film layer formed on sidewalls of the source and drain contact holes, a metal layer deposited to fill the source and drain contact holes, a second oxide film layer formed on sidewalls of the gate contact holes, a metal layer deposited to fill the gate contact holes. Further the method includes growing an oxide film layer on the sidewalls of the contact holes between completing the contact etching process and filling the contact holes with the metal layer, followed by removing with etching the oxide film layer from the gates. Sizes of contact holes can be adjusted thereby.

Abstract: The disclosure provides a FDSOI semiconductor structure and methods to fabricate it. The structure includes source and drain regions and gates respectively in an NMOS area and a PMOS area, a first oxide film layer formed on sidewalls of the source and drain contact holes, a metal layer deposited to fill the source and drain contact holes, a second oxide film layer formed on sidewalls of the gate contact holes, a metal layer deposited to fill the gate contact holes. Further the method includes growing an oxide film layer on the sidewalls of the contact holes between completing the contact etching process and filling the contact holes with the metal layer, followed by removing with etching the oxide film layer from the gates. Sizes of contact holes can be adjusted thereby.

Abstract: Disclosed are 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine and the salt thereof, as well as the preparation method and medical use thereof. The compound can be useful for the preparation of medicaments for treating cardiovascular diseases, especially arrhythmia.

Abstract: Disclosed are 1,2,3,4,5,6,7,8-octohydro-9-phenylacetamidoacridine and the salt thereof, as well as the preparation method and medical use thereof. The compound can be useful for the preparation of medicaments for treating cardiovascular diseases, especially arrhythmia.